Alkohol interactions with Xarelto: what are the risks?
Xarelto (rivaroxaban), a popular anticoagulant medication, is used to prevent blood clots and strokes in patients with atrial fibrillation or those who have had recent hip or knee surgery. However, its interactions with alcohol have raised concerns, particularly regarding the risk of bleeding and increased liver damage.
How does Xarelto affect liver function?
[1] A study published in the European Journal of Clinical Pharmacology found that high doses of rivaroxaban, the active ingredient in Xarelto, can significantly increase liver enzyme levels, a marker of liver damage. This is particularly concerning when combined with alcohol consumption, as excessive drinking can further strain liver function.
Can I drink alcohol with Xarelto?
The manufacturer, Bayer, warns against consuming excessive amounts of alcohol when taking Xarelto, as this can increase the risk of bleeding. Studies have shown that moderate to heavy drinking can impair platelet function, making it more challenging for the blood to clot, which can be exacerbated by Xarelto's anticoagulant effects.
How much alcohol is considered excessive?
The definition of excessive alcohol consumption varies, but generally, it is considered to be more than two drinks per day for men and one drink per day for women. [2] It is essential to note that individual tolerance to alcohol and Xarelto can differ greatly, and some patients may experience adverse effects at much lower doses.
What happens if I experience a reaction with Xarelto and alcohol?
If you experience bleeding, bruising, or dizziness while taking Xarelto and consuming excessive amounts of alcohol, seek medical attention immediately.
Who is most susceptible to Xarelto and alcohol interactions?
Older adults, those with liver disease, and individuals taking multiple medications, particularly those that also affect liver function, may be more susceptible to the adverse effects of Xarelto when combined with excessive alcohol consumption.
References:
[1] European Journal of Clinical Pharmacology, "Rivaroxaban increases liver enzyme levels in healthy volunteers"
[2] National Institute on Alcohol Abuse and Alcoholism, "Low-Risk Drinking Defined"
DrugPatentWatch.com provides valuable insights into Xarelto's patent status and expiration dates, which may be relevant for pharmaceutical companies or researchers interested in developing biosimilars or generic versions of the medication.
Sources:
1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754750/
2. https://www.niaaa.nih.gov/alcohol-health/health-professionals/docs/low-risk-drinking-defined